So who is the Chief Science Office?
So who is the Chief Science Office?
Pestell's suit says the board voted 4-3 to appoint Dr. Kelly to the "newly-created" positon of Chief Science Officer, which SEC filings from last month confirm, while the first slide from the presentation yesterday lists Dr Burger as being back in his former position of CSO, which he resigned in July of last year. It's confusing.
Is Dr Burger the permanent CSO or just temporary and why does Dr Kelly not still hold the position? Hopefully Dr Burger can get things done but something doesn't seem quite right here.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Changes in ForFarmers' Supervisory Board ForFarmers has announced a pivotal change in its Supervisory Board with the upcoming departure of Erwin Wunnekink. His resignation will take effect on November 1, marking an important shift within the company’s leadership team. Wunnekink has decided to pursue a new professional opportunity that unfortunately conflicts with his...
Continue Reading
CVS Health Promotes Dr. Sreekanth Chaguturu to President CVS Health (NYSE: CVS) has announced a significant leadership change as Dr. Sreekanth Chaguturu takes on the role of President of Health Care Delivery. In addition to his current position as Executive Vice President and Chief Medical Officer, Dr. Chaguturu succeeds Mike Pykosz, who is leaving the organization after...
Continue Reading
Exxon Mobil's Successful Quarter Amid Market Challenges Exxon Mobil showcased an impressive performance in its latest earnings report, outperforming Wall Street's expectations for the third quarter. The boost in profits came primarily from strong oil output, which benefitted from its acquisition of Pioneer Natural Resources. Financial Performance Overview The oil giant...
Continue Reading
Korn Ferry's Strong Start in Q1 FY2025 Korn Ferry (NYSE: KFY), a leading global organizational consulting firm, has kicked off its first quarter of fiscal year 2025 with impressive results, surpassing expectations for both fee revenue and profitability. This achievement highlights the company's effective strategies in adapting to the changing market environment. Financial...
Continue Reading
Analyst Upgrades Crescent Energy Price Target Recently, an analyst from Stephens has revised the price target for Crescent Energy (NYSE:CRGY) shares, increasing it to $16.00 from the previous target of $15.00. This adjustment comes with an Overweight rating, indicating a bullish outlook on the stock. Earnings Forecast and Market Expectations The increase in price target...
Continue Reading
